Title : Cholinesterase inhibitors are associated with reduced mortality in patients with Alzheimer's disease and previous myocardial infarction - Shahim_2024_Eur.Heart.J.Cardiovasc.Pharmacother_10_128 |
Author(s) : Shahim B , Xu H , Haugaa K , Zetterberg H , Jurga J , Religa D , Eriksdotter M |
Ref : Eur Heart J Cardiovasc Pharmacother , 10 :128 , 2024 |
Abstract : |
PubMedSearch : Shahim_2024_Eur.Heart.J.Cardiovasc.Pharmacother_10_128 |
PubMedID: 38224338 |
Title : Differential effects of familial Alzheimer's disease-causing mutations on amyloid precursor protein (APP) trafficking, proteolytic conversion, and synaptogenic activity - Schilling_2023_Acta.Neuropathol.Commun_11_87 |
Author(s) : Schilling S , Pradhan A , Heesch A , Helbig A , Blennow K , Koch C , Bertgen L , Koo EH , Brinkmalm G , Zetterberg H , Kins S , Eggert S |
Ref : Acta Neuropathologica Commun , 11 :87 , 2023 |
Abstract : |
PubMedSearch : Schilling_2023_Acta.Neuropathol.Commun_11_87 |
PubMedID: 37259128 |
Title : Quantification of the trans-synaptic partners neurexin-neuroligin in CSF of neurodegenerative diseases by parallel reaction monitoring mass spectrometry - Camporesi_2022_EBioMedicine_75_103793 |
Author(s) : Camporesi E , Nilsson J , Vrillon A , Cognat E , Hourregue C , Zetterberg H , Blennow K , Becker B , Brinkmalm A , Paquet C , Brinkmalm G |
Ref : EBioMedicine , 75 :103793 , 2022 |
Abstract : |
PubMedSearch : Camporesi_2022_EBioMedicine_75_103793 |
PubMedID: 34990894 |
Title : Changes in Adiposity and Cerebrospinal Fluid Biomarkers Following a Modified Mediterranean Ketogenic Diet in Older Adults at Risk for Alzheimer's Disease - Brinkley_2022_Front.Neurosci_16_906539 |
Author(s) : Brinkley TE , Leng I , Register TC , Neth BJ , Zetterberg H , Blennow K , Craft S |
Ref : Front Neurosci , 16 :906539 , 2022 |
Abstract : |
PubMedSearch : Brinkley_2022_Front.Neurosci_16_906539 |
PubMedID: 35720727 |
Title : Evidence of upregulation of the cholinergic anti-inflammatory pathway in late-life depression - Pomara_2021_J.Affect.Disord_286_275 |
Author(s) : Pomara N , Bruno D , Plaska CR , Pillai A , Ramos-Cejudo J , Osorio R , Imbimbo BP , Heslegrave A , Zetterberg H , Blennow K |
Ref : J Affect Disord , 286 :275 , 2021 |
Abstract : |
PubMedSearch : Pomara_2021_J.Affect.Disord_286_275 |
PubMedID: 33756305 |
Title : Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers - Camporesi_2021_Acta.Neuropathol.Commun_9_19 |
Author(s) : Camporesi E , Lashley T , Gobom J , Lantero-Rodriguez J , Hansson O , Zetterberg H , Blennow K , Becker B |
Ref : Acta Neuropathologica Commun , 9 :19 , 2021 |
Abstract : |
PubMedSearch : Camporesi_2021_Acta.Neuropathol.Commun_9_19 |
PubMedID: 33522967 |
Title : Effects of Peroral Omega-3 Fatty Acid Supplementation on Cerebrospinal Fluid Biomarkers in Patients with Alzheimer's Disease: A Randomized Controlled Trial-The OmegAD Study - Tofiq_2021_J.Alzheimers.Dis__ |
Author(s) : Tofiq A , Zetterberg H , Blennow K , Basun H , Cederholm T , Eriksdotter M , Faxen-Irving G , Hjorth E , Jerneren F , Schultzberg M , Wahlund LO , Palmblad J , Freund-Levi Y |
Ref : J Alzheimers Dis , : , 2021 |
Abstract : |
PubMedSearch : Tofiq_2021_J.Alzheimers.Dis__ |
PubMedID: 34420949 |
Title : [Alzheimer's disease - the most common cause of dementia] - Bogdanovic_2020_Lakartidningen_117_ |
Author(s) : Bogdanovic N , Hansson O , Zetterberg H , Basun H , Ingelsson M , Lannfelt L , Blennow K |
Ref : Lakartidningen , 117 : , 2020 |
Abstract : |
PubMedSearch : Bogdanovic_2020_Lakartidningen_117_ |
PubMedID: 32154904 |
Title : Reduced cerebrospinal fluid concentration of interleukin-12\/23 subunit p40 in patients with cognitive impairment - Johansson_2017_PLoS.One_12_e0176760 |
Author(s) : Johansson P , Almqvist EG , Wallin A , Johansson JO , Andreasson U , Blennow K , Zetterberg H , Svensson J |
Ref : PLoS ONE , 12 :e0176760 , 2017 |
Abstract : |
PubMedSearch : Johansson_2017_PLoS.One_12_e0176760 |
PubMedID: 28464009 |
Title : Cerebrospinal Fluid (CSF) 25-Hydroxyvitamin D Concentration and CSF Acetylcholinesterase Activity Are Reduced in Patients with Alzheimer's Disease - Johansson_2013_PLoS.One_8_e81989 |
Author(s) : Johansson P , Almqvist EG , Johansson JO , Mattsson N , Andreasson U , Hansson O , Wallin A , Blennow K , Zetterberg H , Svensson J |
Ref : PLoS ONE , 8 :e81989 , 2013 |
Abstract : |
PubMedSearch : Johansson_2013_PLoS.One_8_e81989 |
PubMedID: 24312390 |
Title : Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease - Parnetti_2011_Acta.Neurol.Scand_124_122 |
Author(s) : Parnetti L , Chiasserini D , Andreasson U , Ohlson M , Huls C , Zetterberg H , Minthon L , Wallin AK , Andreasen N , Talesa VN , Blennow K |
Ref : Acta Neurologica Scandinavica , 124 :122 , 2011 |
Abstract : |
PubMedSearch : Parnetti_2011_Acta.Neurol.Scand_124_122 |
PubMedID: 20880294 |
Title : Computerized cognition assessment during acetylcholinesterase inhibitor treatment in Alzheimer's disease - Wesnes_2010_Acta.Neurol.Scand_122_270 |
Author(s) : Wesnes K , Edgar C , Andreasen N , Annas P , Basun H , Lannfelt L , Zetterberg H , Blennow K , Minthon L |
Ref : Acta Neurologica Scandinavica , 122 :270 , 2010 |
Abstract : |
PubMedSearch : Wesnes_2010_Acta.Neurol.Scand_122_270 |
PubMedID: 20047570 |
Title : The stability of AQT processing speed, ADAS-Cog and MMSE during acetylcholinesterase inhibitor treatment in Alzheimer's disease - Wiig_2010_Acta.Neurol.Scand_121_186 |
Author(s) : Wiig EH , Annas P , Basun H , Andreasen N , Lannfelt L , Zetterberg H , Blennow K , Minthon L |
Ref : Acta Neurologica Scandinavica , 121 :186 , 2010 |
Abstract : |
PubMedSearch : Wiig_2010_Acta.Neurol.Scand_121_186 |
PubMedID: 19785641 |
Title : CSF biomarkers predict a more malignant outcome in Alzheimer disease - Wallin_2010_Neurology_74_1531 |
Author(s) : Wallin AK , Blennow K , Zetterberg H , Londos E , Minthon L , Hansson O |
Ref : Neurology , 74 :1531 , 2010 |
Abstract : |
PubMedSearch : Wallin_2010_Neurology_74_1531 |
PubMedID: 20458070 |
Title : Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial - Lannfelt_2008_Lancet.Neurol_7_779 |
Author(s) : Lannfelt L , Blennow K , Zetterberg H , Batsman S , Ames D , Harrison J , Masters CL , Targum S , Bush AI , Murdoch R , Wilson J , Ritchie CW |
Ref : Lancet Neurol , 7 :779 , 2008 |
Abstract : |
PubMedSearch : Lannfelt_2008_Lancet.Neurol_7_779 |
PubMedID: 18672400 |
Title : Longitudinal stability of CSF biomarkers in Alzheimer's disease - Blennow_2007_Neurosci.Lett_419_18 |
Author(s) : Blennow K , Zetterberg H , Minthon L , Lannfelt L , Strid S , Annas P , Basun H , Andreasen N |
Ref : Neuroscience Letters , 419 :18 , 2007 |
Abstract : |
PubMedSearch : Blennow_2007_Neurosci.Lett_419_18 |
PubMedID: 17482358 |
Title : Alzheimer's disease - Blennow_2006_Lancet_368_387 |
Author(s) : Blennow K , de Leon MJ , Zetterberg H |
Ref : Lancet , 368 :387 , 2006 |
Abstract : |
PubMedSearch : Blennow_2006_Lancet_368_387 |
PubMedID: 16876668 |